Search Results - "Godbout, K"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Recommendations from a Canadian Delphi consensus study on best practice for optimal referral and appropriate management of severe asthma by Godbout, K, Bhutani, M, Connors, L, Chan, C K N, Connors, C, Dorscheid, D, Dyck, G, Foran, V, Kaplan, A G, Reynolds, J, Waserman, S

    Published in Allergy, asthma, and clinical immunology (17-02-2023)
    “…In Canada, severe asthma affects an estimated 5-10% of people with asthma and is associated with frequent exacerbations, poor symptom control and significant…”
    Get full text
    Journal Article
  2. 2

    Significance of Stenotrophomonas maltophilia When Detected in Sputum of Ambulatory Patients with COPD by Soumagne, Thibaud, Levesque, Florence, Milot, Julie, Godbout, Krystelle, Lacasse, Yves, Maltais, François

    “…is an emerging Gram-negative MDR bacteria. In patients with chronic obstructive pulmonary disease (COPD), it is mostly found in those with severe exacerbation…”
    Get full text
    Journal Article
  3. 3

    A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9 by Donoghue, Mary, Hsieh, Frank, Baronas, Elizabeth, Godbout, Kevin, Gosselin, Michael, Stagliano, Nancy, Donovan, Michael, Woolf, Betty, Robison, Keith, Jeyaseelan, Raju, Breitbart, Roger E, Acton, Susan

    Published in Circulation research (01-09-2000)
    “…ACE2, the first known human homologue of angiotensin-converting enzyme (ACE), was identified from 5′ sequencing of a human heart failure ventricle cDNA…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Anti-IL5/IL5R Treatment in COPD: Should We Target Oral Corticosteroid-Dependent Patients? by Laroche, Jérémy, Pelletier, Geneviève, Boulay, Marie-Ève, Côté, Andréanne, Godbout, Krystelle

    “…Monoclonal antibodies targeting interleukin 5 (IL5) or its receptor (IL5R) are frequently used in severe asthma, in which they reduce exacerbations rate and…”
    Get full text
    Journal Article
  6. 6

    Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase by Vickers, Chad, Hales, Paul, Kaushik, Virendar, Dick, Larry, Gavin, James, Tang, Jin, Godbout, Kevin, Parsons, Thomas, Baronas, Elizabeth, Hsieh, Frank, Acton, Susan, Patane, Michael, Nichols, Andrew, Tummino, Peter

    Published in The Journal of biological chemistry (26-04-2002)
    “…Human angiotensin-converting enzyme-related carboxypeptidase (ACE2) is a zinc metalloprotease whose closest homolog is angiotensin I-converting enzyme. To…”
    Get full text
    Journal Article
  7. 7

    Increase in FeNO Levels Following IL5/IL5R-Targeting Therapies in Severe Asthma: A Case Series by Pelletier, Geneviève, Godbout, Krystelle, Boulay, Marie-Ève, Boulet, Louis-Philippe, Morissette, Mathieu C, Côté, Andréanne

    Published in Journal of asthma and allergy (01-01-2022)
    “…Monoclonal antibodies targeting interleukin-5 (IL5) and its receptor (IL5R), used for severe asthma treatment, reduce eosinophils to almost complete depletion…”
    Get full text
    Journal Article
  8. 8

    Construction and characterization of a radio-iodinatable mutant of recombinant human CD4 by Ferrer, Marc, Godbout, Kevin L, Sullivan, Barbara J, Austen, Douglas A, Sanderson, Christine T, Kelley, Kevin C, Osburne, Marcia S, Harrison, Stephen C, van Schravendijk, Marie R

    Published in Journal of immunological methods (29-12-1997)
    “…Recombinant soluble human CD4 (rsCD4) has been used in iodinated form to study the interaction of CD4 with its ligands. However, the utility of [ 125 I ]-rsCD4…”
    Get full text
    Journal Article
  9. 9

    Structural and functional characterization of an epitope in the conserved C-terminal region of HIV-1 gp120 by Ferrer, M., Sullivan, B.J., Godbout, K.L., Burke, E., Stump, H.S., Godoy, J., Golden, A., Profy, A.T., Van Schravendijk, M.R.

    Published in The journal of peptide research (01-07-1999)
    “…: Through an integrated study of the reactivity of a monoclonal antibody, 803‐15.6, with synthetic peptides and native recombinant HIV‐1 envelope glycoprotein…”
    Get full text
    Journal Article